Sanjeev Kothari is a notable inventor based in South San Francisco, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 3 patents to his name, Kothari's work focuses on enhancing the efficacy and delivery of pharmaceutical compounds.

Latest Patents

Kothari's latest patents include the development of immediate-release tablets containing cobimetinib. This patent details a rapid-release pharmaceutical dosage unit that includes a drug that inhibits the mitogen-activated protein kinase enzyme, along with a filler and a disintegrant. The methods for forming these tablets are also outlined, emphasizing the processes for preparing them from granules formed by dry granulation. Another significant patent involves crystalline and mesomorphous forms of an AKT inhibiting pyrimidinyl-cyclopentane compound. This patent discloses various forms, formulations, and pharmaceutical compositions, along with the processes of manufacturing and methods of use.

Career Highlights

Sanjeev Kothari is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to contribute to groundbreaking advancements in the pharmaceutical industry.

Collaborations

Kothari has collaborated with several talented individuals in his field, including Paroma Chakravarty and Francis Gosselin. These collaborations have further enriched his research and development efforts.

Conclusion

Sanjeev Kothari's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of pharmaceutical science and a dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.